Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Embolization of Arterial Hemorrhages in the Peripheral Vasculature: The LAVA Study

NCT04649255 is registered in ClinicalTrials.gov with BlackSwan Vascular, Inc. as lead sponsor.

NCT NCT04649255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04649255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Embolization of Arterial Hemorrhages in the Peripheral Vasculature: The LAVA Study
Lead sponsor
BlackSwan Vascular, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 14, 2021
Completion date
August 17, 2022
Enrollment
113 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial hemorrhage